Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 14, 2024; 30(10): 1431-1449
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1431
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1431
Figure 6 Double-label immunofluorescence analysis in the rat colon.
A and B: Double-label immunofluorescence analysis of serotonin receptor 2B (5-HT2B receptor) (green) and transient receptor potential vanilloid type 1 (TRPV1) (red) in the colon mucosa layer (A) and muscular layer (B) in normal control rats, irritable bowel syndrome with diarrhea (IBS-D) + Vehilce rats and RS-127445-treated IBS-D rats. Merged image showing colocalization (yellow) of the 5-HT2B receptor and TRPV1 immunoreaction. Magnification 20 ×; C: The data are the percentages of 5-HT2B receptor I+ cells in the colon mucosa layer among the total 5-HT2B receptor-immunoreactive (IR) cells in the colon mucosa layer (5-HT2B receptor IT); D: The data are presented as the percentage of 5-HT2B receptor I+ cells in the colon muscular layer relative to the total 5-HT2B IR cells in the colon muscular layer (5-HT2B receptor IT). aP < 0.05, bP < 0.01. IBS-D: Irritable bowel syndrome with diarrhea; 5-HT2B: Serotonin receptor 2B; TRPV1: Transient receptor potential vanilloid type 1.
- Citation: Li ZY, Mao YQ, Hua Q, Sun YH, Wang HY, Ye XG, Hu JX, Wang YJ, Jiang M. Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2024; 30(10): 1431-1449
- URL: https://www.wjgnet.com/1007-9327/full/v30/i10/1431.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i10.1431